Bank of America’s Kiora Pharmaceuticals KPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-29
Closed -$57 6355
2025
Q4
$57 Buy
29
+4
+16% +$9 ﹤0.01% 6930
2025
Q3
$70 Buy
25
+4
+19% +$11 ﹤0.01% 7933
2025
Q2
$61 Buy
21
+1
+5% +$3 ﹤0.01% 8061
2025
Q1
$60 Hold
20
﹤0.01% 7937
2024
Q4
$66 Sell
20
-2
-9% -$7 ﹤0.01% 7820
2024
Q3
$80 Buy
22
+2
+10% +$8 ﹤0.01% 7757
2024
Q2
$84 Buy
+20
New +$93 ﹤0.01% 7739
2023
Q3
Sell
-544
Closed -$3.14K 7860
2023
Q2
$3.14K Buy
+544
New +$11.4K ﹤0.01% 7074
2022
Q1
Hold
0
8521
2021
Q4
Hold
0
8438
2021
Q2
Hold
0
7912
2021
Q1
Hold
0
7603
2020
Q2
Sell
-2
Closed -$4K 6972
2020
Q1
$4K Buy
+2
New +$4.3K ﹤0.01% 6529
2019
Q4
Hold
0
7248
2019
Q3
Hold
0
7371
2017
Q4
Hold
0
-$1K 7139
2017
Q3
Hold
0
6930
2017
Q2
Hold
0
6815
2017
Q1
Hold
0
6854
2016
Q4
Hold
0
6904
2016
Q3
Hold
0
6933
2016
Q2
Hold
0
6991
2016
Q1
Hold
0
6775

Other funds holding KPRX

Bank of America's KPRX Position: Q1 2026 in Review

Bank of America sold out of Kiora Pharmaceuticals (KPRX) in Q1 2026, closing a stake of 29 shares — an estimated $57 sold.

Bank of America first reported a position in KPRX in Q1 2020 and held it in 9 quarters. The position peaked at $4K in Q1 2020. 18 funds tracked by Wall St. Rank hold KPRX as of Q1 2026.

  • Bank of America reported no remaining Kiora Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 29 Kiora Pharmaceuticals shares in Q1 2026, an estimated $57.
  • Bank of America first reported a position in Kiora Pharmaceuticals in Q1 2020 and held it in 9 quarters.
  • Bank of America's Kiora Pharmaceuticals position peaked at $4K in Q1 2020.
  • 18 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.